Thoracic cancer
Therapeutic area
Oncology
Rare disease
No
- Definition
- A primary or metastatic malignant neoplasm affecting the tissues of the thorax.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Thoracic cancer
- Therapeutic area
- Oncology
- thoracic cancer
- thoracic tumor
- thoracic tumour
- thorax neoplasm
- tumor of thorax
- tumour of thorax
- cancer of thoracic segment of trunk
- malignant neoplasm of the thorax
- malignant neoplasm of thoracic segment of trunk
- malignant neoplasm of thorax
- malignant thoracic neoplasm
- malignant thoracic segment of trunk neoplasm
- malignant thoracic tumor
- malignant thoracic tumour
- malignant tumor of the thorax
- malignant tumor of thorax
- malignant tumour of the thorax
- malignant tumour of thorax
- thoracic segment of trunk cancer
- All therapeutic areas
- Oncology
- Severity
- Severe
- MONDO ID
- MONDO:0003274
- Parent condition
- MONDO:0004992
Related records
Broader conditions (8)
- Cancer
- Cancer or benign tumor
- Disease
- Disease by etiologic mechanism
- Human disease
- Neoplasm
- Neoplasm of thorax
- Neoplastic disease or syndrome
Narrower conditions (211)
- Acantholytic variant squamous cell breast carcinoma
- Acinar lung adenocarcinoma
- Acinic cell breast carcinoma
- Adenoid cystic breast carcinoma
- Adenosquamous breast carcinoma
- Adenosquamous lung carcinoma
- Asbestos-related lung carcinoma
- Askin tumor
- Atypical lobular breast hyperplasia
- Basal-like breast carcinoma
- Basaloid large cell lung carcinoma
- Bilateral breast carcinoma
- Breast adenocarcinoma
- Breast angiosarcoma
- Breast apocrine carcinoma
- Breast apocrine carcinoma in situ
- Breast cancer
- Breast carcinoma
- Breast carcinoma by gene expression profile
- Breast carcinoma in situ
Trials (196)
- (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
- (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC
- (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC
- 3DPCT Combined With CT Guided RISI in the Treatment of Thoracic Malignant Tumors
- A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers
- A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
- A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy
- A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer
- A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer
- A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
- A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection
- A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System
- A Prospective Study Frailty for Esophagectomy and Lung Resection in Thoracic Surgery
- A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
- A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC
- A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma
- A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic Tumors
- A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
- A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer